Use of Circulating Extracellular Vesicles and CtDNA From Lymphatic Fluid Exudate as Markers for Minimal Residual Disease in Melanoma Patients

• Enrique Baston,
• C. Mayo de las Casas,
• M. Garzón,
• S. Barrio,
• M. Molina,
• S. Garcia Silva,
• M. González Cao,
• H. Peinado Selgas

Affiliations

Enrique Baston

Microenvironment and Metastasis Laboratory, Molecular Oncology Programme. Spanish National Cancer Research Centre (CNIO), Madrid, Spain

C. Mayo de las Casas

Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain

M. Garzón

Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain

S. Barrio

Altum Sequencing Co., Madrid, Spain; Department of Hematology, Hospital Universitario 12 de Octubre, CNIO, CIBERONC, Madrid, Spain

M. Molina

Laboratory of Oncology, Pangaea Oncology, Quirón Dexeus University Hospital, Barcelona, Spain

S. Garcia Silva

Microenvironment and Metastasis Laboratory, Molecular Oncology Programme. Spanish National Cancer Research Centre (CNIO), Madrid, Spain

M. González Cao

Translational Cancer Research Unit, Instituto Oncológico Dr Rosell, Dexeus University Hospital, Barcelona, Spain

H. Peinado Selgas

Microenvironment and Metastasis Laboratory, Molecular Oncology Programme. Spanish National Cancer Research Centre (CNIO), Madrid, Spain